Roles of IL-2 in bridging adaptive and innate immunity, and as a tool for cellular immunotherapy

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F20%3A00072912" target="_blank" >RIV/00159816:_____/20:00072912 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00023736:_____/20:00013017

Výsledek na webu

<a href="https://jlb.onlinelibrary.wiley.com/doi/full/10.1002/JLB.5MIR0420-055R" target="_blank" >https://jlb.onlinelibrary.wiley.com/doi/full/10.1002/JLB.5MIR0420-055R</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1002/JLB.5MIR0420-055R" target="_blank" >10.1002/JLB.5MIR0420-055R</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Roles of IL-2 in bridging adaptive and innate immunity, and as a tool for cellular immunotherapy

Popis výsledku v původním jazyce

IL-2 was initially characterized as a T cell growth factor in the 1970s, and has been studied intensively ever since. Decades of research have revealed multiple and diverse roles for this potent cytokine, indicating a unique linking role between adaptive and innate arms of the immune system. Here, we review the literature showing that IL-2 is expressed in a plethora of cell types across the immune system, where it has indispensable functions in orchestrating cellular interactions and shaping the nature and magnitude of immune responses. Emerging from the basic research that has revealed the molecular mechanisms and the complexity of the biologic actions of IL-2, several immunotherapeutic approaches have now focused on manipulating the levels of this cytokine in patients. These strategies range from inhibition of IL-2 to achieve immunosuppression, to the application of IL-2 as a vaccine adjuvant and in cancer therapies. This review will systematically summarize the major findings in the field and identify key areas requiring further research in order to realize the potential of IL-2 in the treatment of human diseases.

Název v anglickém jazyce

Roles of IL-2 in bridging adaptive and innate immunity, and as a tool for cellular immunotherapy

Popis výsledku anglicky

IL-2 was initially characterized as a T cell growth factor in the 1970s, and has been studied intensively ever since. Decades of research have revealed multiple and diverse roles for this potent cytokine, indicating a unique linking role between adaptive and innate arms of the immune system. Here, we review the literature showing that IL-2 is expressed in a plethora of cell types across the immune system, where it has indispensable functions in orchestrating cellular interactions and shaping the nature and magnitude of immune responses. Emerging from the basic research that has revealed the molecular mechanisms and the complexity of the biologic actions of IL-2, several immunotherapeutic approaches have now focused on manipulating the levels of this cytokine in patients. These strategies range from inhibition of IL-2 to achieve immunosuppression, to the application of IL-2 as a vaccine adjuvant and in cancer therapies. This review will systematically summarize the major findings in the field and identify key areas requiring further research in order to realize the potential of IL-2 in the treatment of human diseases.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

10601 - Cell biology

Projekt

Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2020

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Journal of leukocyte biology

ISSN

0741-5400

e-ISSN

—

Svazek periodika

108

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

11

Strana od-do

427-437

Kód UT WoS článku

000536718100001

EID výsledku v databázi Scopus

—